While there are encouraging signs of reimbursement falling in step with the move towards a more value-based healthcare system, what is needed now to further encourage healthcare innovators is to properly rationalize approval processes imposed by the FDA and CMS.

Change is often driven by necessity, and in the short time since the outbreak of Covid-19, we have witnessed the potential of technology to transform healthcare delivery and save lives. From patient appointments using online chat services, to AI-powered robots protecting healthcare workers by delivering medicine in Covid-19 surge clinics; and rapid remote analysis of cardiac images helping with the triage of high-risk patients*.

The task ahead is to make sure that we don’t forget the value and impact of what we have seen technology, and particularly AI can do — and the resulting benefits of easing the ongoing pressure on healthcare providers, while giving patients the best possible chance of living a healthy life.

Source: medcitynews.com